Cargando…
Low-dose lacosamide-induced atrial fibrillation: Case analysis with literature review()()
Lacosamide (LCM) is a novel antiepileptic drug (AED) approved by the FDA for adjunctive treatment of partial epilepsy with and without secondary generalization. Lacosamide dose-dependent dysrhythmias (PR-interval prolongation, AV block, and atrial fibrillation/flutter) have been reported. This case...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150593/ https://www.ncbi.nlm.nih.gov/pubmed/25688049 http://dx.doi.org/10.1016/j.ebcr.2012.10.006 |
_version_ | 1782332929531183104 |
---|---|
author | Kaufman, Kenneth R. Velez, Arnaldo E. Wong, Stephen Mani, Ram |
author_facet | Kaufman, Kenneth R. Velez, Arnaldo E. Wong, Stephen Mani, Ram |
author_sort | Kaufman, Kenneth R. |
collection | PubMed |
description | Lacosamide (LCM) is a novel antiepileptic drug (AED) approved by the FDA for adjunctive treatment of partial epilepsy with and without secondary generalization. Lacosamide dose-dependent dysrhythmias (PR-interval prolongation, AV block, and atrial fibrillation/flutter) have been reported. This case represents the first instance of LCM-induced atrial fibrillation following a low loading dose (200 mg). Risk factors for atrial fibrillation are addressed and discussed in the context of this case. Full cardiac history is recommended prior to patients being initiated on LCM. Cardiac monitoring may be required for at-risk patients on LCM. Clinicians need to be cognizant of this potential adverse effect. |
format | Online Article Text |
id | pubmed-4150593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-41505932015-02-09 Low-dose lacosamide-induced atrial fibrillation: Case analysis with literature review()() Kaufman, Kenneth R. Velez, Arnaldo E. Wong, Stephen Mani, Ram Epilepsy Behav Case Rep Case Report Lacosamide (LCM) is a novel antiepileptic drug (AED) approved by the FDA for adjunctive treatment of partial epilepsy with and without secondary generalization. Lacosamide dose-dependent dysrhythmias (PR-interval prolongation, AV block, and atrial fibrillation/flutter) have been reported. This case represents the first instance of LCM-induced atrial fibrillation following a low loading dose (200 mg). Risk factors for atrial fibrillation are addressed and discussed in the context of this case. Full cardiac history is recommended prior to patients being initiated on LCM. Cardiac monitoring may be required for at-risk patients on LCM. Clinicians need to be cognizant of this potential adverse effect. Elsevier 2012-11-08 /pmc/articles/PMC4150593/ /pubmed/25688049 http://dx.doi.org/10.1016/j.ebcr.2012.10.006 Text en © 2012 The Authors http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/). |
spellingShingle | Case Report Kaufman, Kenneth R. Velez, Arnaldo E. Wong, Stephen Mani, Ram Low-dose lacosamide-induced atrial fibrillation: Case analysis with literature review()() |
title | Low-dose lacosamide-induced atrial fibrillation: Case analysis with literature review()() |
title_full | Low-dose lacosamide-induced atrial fibrillation: Case analysis with literature review()() |
title_fullStr | Low-dose lacosamide-induced atrial fibrillation: Case analysis with literature review()() |
title_full_unstemmed | Low-dose lacosamide-induced atrial fibrillation: Case analysis with literature review()() |
title_short | Low-dose lacosamide-induced atrial fibrillation: Case analysis with literature review()() |
title_sort | low-dose lacosamide-induced atrial fibrillation: case analysis with literature review()() |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150593/ https://www.ncbi.nlm.nih.gov/pubmed/25688049 http://dx.doi.org/10.1016/j.ebcr.2012.10.006 |
work_keys_str_mv | AT kaufmankennethr lowdoselacosamideinducedatrialfibrillationcaseanalysiswithliteraturereview AT velezarnaldoe lowdoselacosamideinducedatrialfibrillationcaseanalysiswithliteraturereview AT wongstephen lowdoselacosamideinducedatrialfibrillationcaseanalysiswithliteraturereview AT maniram lowdoselacosamideinducedatrialfibrillationcaseanalysiswithliteraturereview |